ConductScience.org, home

Paper9880552

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.

McKay RA and 5 others. J Biol Chem, 1999. Cited by 204 papers, by iCite.

Cite this record

ConductScience Library. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. Papers, record 9880552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9880552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.
PubMed
Journal
J Biol Chem
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
204
iCite
Relative citation ratio, by iCite
3.7
iCite
Revised in PubMed
2021-02-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McKay RAR A
2Miraglia LJL J
3Cummins LLL L
4Owens SRS R
5Sasmor HH
6Dean NMN M

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enzyme InhibitorsMajor topic
Gene Expression Regulation, EnzymologicMajor topic
IsoenzymesMajor topic
Oligodeoxyribonucleotides, AntisenseMajor topic
Protein Kinase CMajor topic
ThionucleotidesMajor topic
Base Sequence
Dose-Response Relationship, Drug
Humans
Molecular Sequence Data
Protein Kinase C-alpha
Proto-Oncogene Proteins c-fos
Proto-Oncogene Proteins c-jun
RNA, Messenger
Tetradecanoylphorbol Acetate
Thermodynamics
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by75

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.

PMIDTitleJournalYearIn PapersSource
42588437Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers.Molecules2026https://conductscience.org/library/papers/42588437PubMed
41226561Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies.Int J Mol Sci2025https://conductscience.org/library/papers/41226561PubMed
40877500Chemical Modifications in Nucleic Acid Therapeutics.Methods Mol Biol2025https://conductscience.org/library/papers/40877500PubMed
40772259Dravet syndrome: novel insights into SCN1A-mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework.Front Neurosci2025https://conductscience.org/library/papers/40772259PubMed
40420562An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome.Elife2025https://conductscience.org/library/papers/40420562PubMed
39376536Antisense oligonucleotides and their applications in rare neurological diseases.Front Neurosci2024https://conductscience.org/library/papers/39376536PubMed
38017665The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations.RNA Biol2024https://conductscience.org/library/papers/38017665PubMed
37830609Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.Cells2023https://conductscience.org/library/papers/37830609PubMed
37264159β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer's disease model mice.Nat Neurosci2023https://conductscience.org/library/papers/37264159PubMed
37243335Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice.Ann Neurol2023https://conductscience.org/library/papers/37243335PubMed
37165619Plumbing mysterious RNAs in "dark genome" for the conquest of human diseases.Mol Ther2023https://conductscience.org/library/papers/37165619PubMed
36173683Antisense oligonucleotide therapy for KCNT1 encephalopathy.JCI Insight2022https://conductscience.org/library/papers/36173683PubMed
36146858Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects.Viruses2022https://conductscience.org/library/papers/36146858PubMed
35807171Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias.J Clin Med2022https://conductscience.org/library/papers/35807171PubMed
34412058Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders.Dev Neurosci2021https://conductscience.org/library/papers/34412058PubMed
33643816Long non-coding RNAs: From disease code to drug role.Acta Pharm Sin B2021https://conductscience.org/library/papers/33643816PubMed
33550655Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model.Ann Neurol2021https://conductscience.org/library/papers/33550655PubMed
32670539RNA interference in glial cells for nerve injury treatment.J Tissue Eng2020https://conductscience.org/library/papers/32670539PubMed
32591626POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices.Sci Rep2020https://conductscience.org/library/papers/32591626PubMed
32589506Treatment with Volanesorsen, a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting APOC3 mRNA, Does Not Affect the QTc Interval in Healthy Volunteers.Nucleic Acid Ther2020https://conductscience.org/library/papers/32589506PubMed

See all 75 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOS2353PubTator's text mininghttps://conductscience.org/library/genes/2353NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene
PRKCA5578PubTator's text mininghttps://conductscience.org/library/genes/5578NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9880552

GET https://conductscience.org/api/papers/v1/9880552/cited_by?page=2